Presentation on ASX Gems Conference on 21st June, page-199

he has time to do media presentations because his part is done and it's now being looked over by others..thats why its "imminent"
better to be done thoroughly even if that means more time. BOT had to adjust their label and it was deemed 6 month review by fda. admittedly there was some sort of human factor usage study submitted. but i think chopper will be right, and our expectations should be for 6 months.
once its submitted they will push on with pre bla meeting lvad . everyone talks about the share price during last resubmission and the cap raise but do they account for the potential added value of a near term submission and the voucher for hlhs